Work

Detection of MRI‐Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy

Year: 2025

Type: article

Abstract: Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion‐harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041

Source: Case Reports in Urology

DOI: 10.1155/criu/2981515